DJIA 16,262.56 89.32 0.55%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 12.37 0.68%
market minute promo

24.03 -0.54 (-2.20%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IPXL $24.03 -2.20%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $24.59
Previous Close $24.57
Daily Range $23.16 - $24.84
52-Week Range $15.91 - $28.50
Market Cap $1.7B
P/E Ratio 16.71
Dividend (Yield) $0.00 (0.0%)
Volume 545,977
Average Daily Volume 678,973
Current FY EPS $0.73

Sector

Healthcare

Industry

Drugs

Impax Laboratories Inc. (IPXL) Description

Impax Laboratories Inc. is a technology-based specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals utilizing its controlled-release and other in-house development. Website: http://www.impaxlabs.com/

News & Commentary Rss Feed

Is Teva's Situation Really So Dire?

Despite Teva’s poor performance recently, it still has several strong points that could revive its stock. How is Teva measuring up to Pfizer and Impax Laboratories?

Regulatory Update from Impax - Analyst Blog

Sector Update: Healthcare Shares Lower in Pre-Market Trade

Sector Update: Healthcare

Impax Pharma Resubmits RYTARY Extended-Release Capsules to FDA

Mallinckrodt plc (MNK) in Focus: Stock Moves 5.3% Higher - Tale of the Tape

Pacira and Patheon Collaborate - Analyst Blog

Additional Data on Pacira's Exparel - Analyst Blog

Actavis Up Slightly on Silom Acquisition - Analyst Blog

Pacira Up as Exparel Site Gets FDA Nod - Analyst Blog

Pacira Up as Exparel Site Gets FDA Nod - Analyst Blog

How Impax Laboratories (IPXL) Stock Stands Out in a Strong Industry - Tale of the Tape

How Impax Laboratories (IPXL) Stock Stands Out in a Strong Industry - Tale of the Tape

See More IPXL News...

IPXL's Top Competitors

IPXL $24.03 (-2.20%)
Current stock: IPXL
PFE $29.89 (0.07%)
Current stock: PFE
JNJ $99.20 (2.12%)
Current stock: JNJ
RHHBY $36.14 (-0.17%)
Current stock: RHHBY